SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193805-14-001682
Filing Date
2014-08-14
Accepted
2014-08-13 18:42:15
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 e612615_10q-retrophin.htm 10-Q 1040855
2 e612615_ex31-1.htm EX-31.1 16381
3 e612615_ex31-2.htm EX-31.2 16032
4 e612615_ex32-1.htm EX-32.1 5971
5 e612615_ex32-2.htm EX-32.2 5829
12 GRAPHIC table.jpg GRAPHIC 45273
  Complete submission text file 0001193805-14-001682.txt   5673716

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rtrx-20140630.xml EX-101.INS 715059
7 XBRL TAXONOMY EXTENSION SCHEMA rtrx-20140630.xsd EX-101.SCH 59760
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rtrx-20140630_cal.xml EX-101.CAL 58986
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rtrx-20140630_def.xml EX-101.DEF 93495
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rtrx-20140630_lab.xml EX-101.LAB 382362
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rtrx-20140630_pre.xml EX-101.PRE 245656
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 0229
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 141038909
SIC: 2834 Pharmaceutical Preparations